| 
	
		|  | 
 
		 
		
			|  |  
			|  |  
			| 
    
        | 
                 
                    |  |   
                    |  : Ͽ Ʋ  5:2  ܽġ̾Ʈ  ̷ ȿ |   
                    | ϾϿ͡Ƣմ ,   5:2  ܽ, ü     ȿ ־̻  氣 ġ ȿ ־Ͽ Ʋ  5:2  ܽ       ġῡ ȿ ִٴ   Դ.   (A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR and PCK1, 5:2  ܽ  PPAR PCK1  ڿü 氣  ȭ ϰ  ߴ Ѵ) м  Ÿ(Cell Metabolism) ֱ ƴ. 
 
  ϾϿ(German Cancer Research Center) Ƣ б(University of Tubingen)  㸦   ܽ  ǰ ġ  Ȯߴ.  㿡   Ĵ 絵    Կ. ٸ, 㸦     쿡     ϰ, ٸ  Ʋ ƹ ͵  ʰ   ϴ ŭ   ϴ 5:2  ܽ ״.  ,  絵       ü߰ ü ϸ ̻  氣(MASH) ϴ  巯. ݸ, 5:2  ܽ      Ծ ü  ʾ,  ջ Ÿ ġ Ҵ. ⼭ ָ    㰡  Įθ ѷ ߴٴ ̴.   ܽ ߿ Ͽ Ʋ  5:2  ܽ Ϸ縦   ٸ º  ȿ̶  ´.  Ȯ Ŀ Ȯϱ    ܹ   Ȱ  ߴ.  ,  ܽ ϸ  ؿ    ִ Żռ(Gluconeogenesis) þ   ϴ PPAR PCK1  ȿҵ Ȱȭȴٴ  ߰ߴ.   Ĵ ̹ MASH ߺ   5:2  ܽ 4  ϴ ߰  ߴ.  ,  ܽ   氣 ġ   ߺ پ  Ÿ. 
 
 |  
                    |  |  |  
 
 |  
			|  |  |  |  |